Cilian Overview

  • Founded
  • 2001

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 11

Employees
  • Latest Deal Type
  • Grant

  • Financing Rounds
  • 5

Cilian General Information

Description

Provider of biotechnology products. The company develops biotechnology and pharmaceutical products for the treatment of cancer, pancreatic diseases and other diseases in Germany.

Contact Information

Website
www.cilian.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Parent Company
Primary Office
  • Johann-Krane-Weg 42
  • 48149 Munster
  • Germany
+49 0251 000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cilian Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cilian‘s full profile, request access.

Request a free trial

Cilian Patents

Cilian Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201501081-D0 Use of enzymes with a wide ph activity range as medicaments for promoting digestion Inactive 22-Jan-2015 0000000000
US-20180073001-A1 Use of enzymes with a wide ph activity range as medicaments for promoting digestion Active 22-Jan-2015 0000000000
CA-2992918-A1 Use of enzymes with a wide ph activity range as medicaments for promoting digestion Pending 22-Jan-2015 0000000000
EP-3247385-A1 Use of enzymes with a wide ph activity range as medicaments for promoting digestion Pending 22-Jan-2015 0000000000
AU-2016208474-B2 Use of enzymes with a wide ph activity range as medicaments for promoting digestion Active 22-Jan-2015 C12N9/20
To view Cilian’s complete patent history, request access »

Cilian Executive Team (4)

Name Title Board Seat Contact Info
Christian Scheiner Chief Executive Officer
Christian Fründ Chief Financial Officer
Marcus Hartmann Ph.D Founder & Chief Scientific Officer
You’re viewing 3 of 4 executive team members. Get the full list »

Cilian Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cilian Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cilian‘s full profile, request access.

Request a free trial